Moderated Discussion – Assessing the Current & Future Landscapes for Preclinical Models
Time: 12:50 pm
day: Day One
Details:
- Dissecting the advantages and disadvantages of current established preclinical models
- Ascertaining what should be done to improve translatability of animal models without extending drug development timeline
- Expanding our understanding of mechanisms driving safety for HFpEF targeted candidates
